CDC Changes Recommendations Due to Severe Nirsevimab Shortage During the 2023-2024 RSV Season
- Zainab Rahmat; Shkaib Ahmad; Abdullah Malikzai
Access Resources
About
This article describes how the CDC changed its recommendations because of a severe shortage of nirsevimab during the 2023-2024 RSV season. Nirsevimab is important for protecting babies and young children from RSV, a virus that causes lung infections. The changes aim to help manage the limited supply of nirsevimab effectively during this time.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.